FEBS Letters
Volume 583, Issue 17 , Pages 2793-2798, 3 September 2009

Ribavirin enhances interferon signaling via stimulation of mTOR and p53 activities

Edited by Giulio Superti-Furga

  • Wen-Cheng Su

      Affiliations

    • Graduate Institute of Molecular Medicine, College of Medicine and Hospital, National Taiwan University, Taipei, Taiwan
  • ,
  • Wei-Liang Liu

      Affiliations

    • Graduate Institute of Clinical Medicine, College of Medicine and Hospital, National Taiwan University, No. 7, Chung-Shan South Rd., Taipei 10002, Taiwan
  • ,
  • Ching-Wei Cheng

      Affiliations

    • Graduate Institute of Molecular Medicine, College of Medicine and Hospital, National Taiwan University, Taipei, Taiwan
  • ,
  • Yu-Bin Chou

      Affiliations

    • Graduate Institute of Clinical Medicine, College of Medicine and Hospital, National Taiwan University, No. 7, Chung-Shan South Rd., Taipei 10002, Taiwan
  • ,
  • Ko-Hsuan Hung

      Affiliations

    • Graduate Institute of Clinical Medicine, College of Medicine and Hospital, National Taiwan University, No. 7, Chung-Shan South Rd., Taipei 10002, Taiwan
  • ,
  • Wen-Hung Huang

      Affiliations

    • Graduate Institute of Clinical Medicine, College of Medicine and Hospital, National Taiwan University, No. 7, Chung-Shan South Rd., Taipei 10002, Taiwan
  • ,
  • Chao-Liang Wu

      Affiliations

    • Departments of Biochemistry, College of Medicine, National Cheng Kung University, Tainan, Taiwan
  • ,
  • Yuan-Tsung Li

      Affiliations

    • Departments of Biochemistry, College of Medicine, National Cheng Kung University, Tainan, Taiwan
  • ,
  • Ai-Li Shiau

      Affiliations

    • Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan
  • ,
  • Ming-Yang Lai

      Affiliations

    • Graduate Institute of Clinical Medicine, College of Medicine and Hospital, National Taiwan University, No. 7, Chung-Shan South Rd., Taipei 10002, Taiwan
    • Department of Internal Medicine, College of Medicine and Hospital, National Taiwan University, Taipei, Taiwan
    • Corresponding Author InformationCorresponding author. Address: Graduate Institute of Clinical Medicine, National Taiwan University Hospital, No. 7, Chung-Shan South Rd., Taipei 10002, Taiwan. Fax: +886 2 23825962.

Received 7 May 2009; received in revised form 8 July 2009; accepted 14 July 2009. published online 20 July 2009.

Abstract 

Cellular mechanisms involving the enhancement of interferon (IFN) signaling by ribavirin remain poorly understood. Here, we identified a novel role of ribavirin in the communication between p53 and the mammalian target of rapamycin (mTOR) signaling. Ribavirin activates p53 by stimulating mTOR and promoting the interaction between mTOR and p53. Activated p53 stimulates the transcription of IFN regulatory factor 9 and subsequently enhances IFN signaling. Furthermore, ribavirin-induced activation of mTOR and p53 enhances IFN-dependent signaling for the IFN-α/ribavirin combined treatment. We conclude that ribavirin enhances activities of mTOR and p53, which may account for its antiviral and antitumor effects.

Structured summary:

MINT-7222801:

mTOR (uniprotkb:P42345) physically interacts (MI:0914) with raptor (uniprotkb:Q8N122) by anti bait coimmunoprecipitation (MI:0006)

MINT-7222793:

mTOR (uniprotkb:P42345) physically interacts (MI:0914) with RICTOR (uniprotkb:Q8N6M7) by anti bait coimmunoprecipitation (MI:0006)

MINT-7222784:

mTOR (uniprotkb:P42345) physically interacts (MI:0914) with P53 (uniprotkb:P04637) by anti bait coimmunoprecipitation (MI:0006)

Keywords: Ribavirin, mTOR, p53, IFN

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0014-5793(09)00557-2

doi:10.1016/j.febslet.2009.07.027

FEBS Letters
Volume 583, Issue 17 , Pages 2793-2798, 3 September 2009